Eupraxia Pharmaceuticals (EPRX) Tax Rate (2024 - 2026)

Eupraxia Pharmaceuticals (EPRX) posted quarterly Tax Rate of 0.11% for Q1 2026, up 7.0% year-over-year from 0.1% in Q1 2025, and up 72.3% quarter-over-quarter from 0.06% in Q2 2025.

Eupraxia Pharmaceuticals (EPRX) Tax Rate (2024 - 2026) Analysis & Trends

Eupraxia Pharmaceuticals (EPRX) has reported Tax Rate for 3 consecutive years, with 0.11% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Tax Rate rose 7.0% year-over-year to 0.11%; the TTM figure through Mar 2026 stood at 0.04% (changed N/A YoY), while the FY2025 annual figure was 0.05%, down 4.0% from the prior year.
  • Tax Rate grew to 0.11% in Q1 2026 per EPRX's latest filing, from 0.06% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.11% in Q1 2026 and bottomed at 0.04% in Q1 2025.
  • Historically, Tax Rate has averaged 0.07% across 3 years, with a median of 0.07% in 2024.
  • Annual changes were most pronounced in 2025 — Tax Rate decreased 4 bps — and 2026, when it grew 7 bps.
  • Eupraxia Pharmaceuticals' Tax Rate stood at 0.08% in 2024, then dropped by 21 bps to 0.06% in 2025, then surged by 72 bps to 0.11% in 2026.
  • Business Quant data shows EPRX's Tax Rate at 0.11% in Q1 2026, 0.06% in Q2 2025, and 0.04% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 15.11%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 10.91%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 24.15%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -9.47%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 7.49%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -16.71%
10 Eupraxia Pharmaceuticals 381.11 Mn 379.51 Mn - 0.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.11%
Mar 31, 2026 0.11%
Mar 31, 2026 0.11%
Jun 30, 2025 0.06%
Jun 30, 2025 0.06%
Jun 30, 2025 0.06%
Mar 31, 2025 0.04%
Mar 31, 2025 0.04%
Mar 31, 2025 0.04%
Mar 31, 2024 0.08%
Mar 31, 2024 0.08%
Mar 31, 2024 0.08%